CD274 and non-small cell lung carcinoma: Forth, due to the small number of patients participating in the study, the efficacy of immunotherapy plus single-agent chemotherapy as a second- or later-line therapy for metastatic non-small cell lung cancer was not explored in terms of actionable alteration status and PD-L1 status.